nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—ANK1—type 2 diabetes mellitus	0.0119	0.038	CbGpPWpGaD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—ANK1—type 2 diabetes mellitus	0.0114	0.0365	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—ANK1—type 2 diabetes mellitus	0.011	0.0352	CbGpPWpGaD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—SCN1B—type 2 diabetes mellitus	0.00969	0.0309	CbGpPWpGaD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—ANK1—type 2 diabetes mellitus	0.00775	0.0247	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SCN1B—type 2 diabetes mellitus	0.00571	0.0182	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—SCN1B—type 2 diabetes mellitus	0.00549	0.0175	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SCN1B—type 2 diabetes mellitus	0.00529	0.0169	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—ANK1—type 2 diabetes mellitus	0.00457	0.0146	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—LAMA1—type 2 diabetes mellitus	0.00444	0.0142	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00439	0.014	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—ANK1—type 2 diabetes mellitus	0.00439	0.014	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—LAMA1—type 2 diabetes mellitus	0.00427	0.0136	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—ANK1—type 2 diabetes mellitus	0.00423	0.0135	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—LAMA1—type 2 diabetes mellitus	0.00411	0.0131	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SCN1B—type 2 diabetes mellitus	0.00372	0.0119	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—ANK1—type 2 diabetes mellitus	0.00297	0.00949	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—LAMA1—type 2 diabetes mellitus	0.00289	0.00923	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00283	0.00904	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—PAX6—type 2 diabetes mellitus	0.00242	0.00772	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00231	0.00737	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SCN1B—type 2 diabetes mellitus	0.00216	0.00689	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00214	0.00685	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00214	0.00685	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SCN1B—type 2 diabetes mellitus	0.00207	0.00662	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAFA—type 2 diabetes mellitus	0.00203	0.00649	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SCN1B—type 2 diabetes mellitus	0.002	0.00638	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAFA—type 2 diabetes mellitus	0.00195	0.00623	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAFA—type 2 diabetes mellitus	0.00188	0.00601	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NKX6-1—type 2 diabetes mellitus	0.00186	0.00593	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—TRPC1—type 2 diabetes mellitus	0.00184	0.00586	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NKX6-1—type 2 diabetes mellitus	0.00179	0.0057	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—TRPC1—type 2 diabetes mellitus	0.00176	0.00563	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00174	0.00254	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00174	0.00253	CcSEcCtD
Prilocaine—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00174	0.00253	CcSEcCtD
Prilocaine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00173	0.00253	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NEUROD1—type 2 diabetes mellitus	0.00173	0.00552	CbGpPWpGaD
Prilocaine—Vomiting—Acarbose—type 2 diabetes mellitus	0.00173	0.00252	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ANK1—type 2 diabetes mellitus	0.00173	0.00551	CbGpPWpGaD
Prilocaine—Shock—Glimepiride—type 2 diabetes mellitus	0.00172	0.00251	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NKX6-1—type 2 diabetes mellitus	0.00172	0.0055	CbGpPWpGaD
Prilocaine—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.00172	0.00251	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—IGF2—type 2 diabetes mellitus	0.00171	0.00547	CbGpPWpGaD
Prilocaine—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00171	0.0025	CcSEcCtD
Prilocaine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.0017	0.00248	CcSEcCtD
Prilocaine—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.0017	0.00248	CcSEcCtD
Prilocaine—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00248	CcSEcCtD
Prilocaine—Drowsiness—Metformin—type 2 diabetes mellitus	0.0017	0.00248	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—TRPC1—type 2 diabetes mellitus	0.0017	0.00543	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00169	0.00247	CcSEcCtD
Prilocaine—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00168	0.00246	CcSEcCtD
Prilocaine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00168	0.00245	CcSEcCtD
Prilocaine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00168	0.00245	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—LAMA1—type 2 diabetes mellitus	0.00168	0.00536	CbGpPWpGaD
Prilocaine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00244	CcSEcCtD
Prilocaine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00167	0.00244	CcSEcCtD
Prilocaine—Somnolence—Glipizide—type 2 diabetes mellitus	0.00167	0.00243	CcSEcCtD
Prilocaine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00167	0.00243	CcSEcCtD
Prilocaine—Neuropathy peripheral—Metformin—type 2 diabetes mellitus	0.00167	0.00243	CcSEcCtD
Prilocaine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00167	0.00243	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NEUROD1—type 2 diabetes mellitus	0.00166	0.0053	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ANK1—type 2 diabetes mellitus	0.00166	0.00529	CbGpPWpGaD
Prilocaine—Tremor—Glyburide—type 2 diabetes mellitus	0.00166	0.00242	CcSEcCtD
Prilocaine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00164	0.0024	CcSEcCtD
Prilocaine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00164	0.00239	CcSEcCtD
Prilocaine—Anaemia—Glyburide—type 2 diabetes mellitus	0.00163	0.00239	CcSEcCtD
Prilocaine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.00163	0.00238	CcSEcCtD
Prilocaine—Nausea—Acarbose—type 2 diabetes mellitus	0.00161	0.00236	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—LAMA1—type 2 diabetes mellitus	0.00161	0.00515	CbGpPWpGaD
Prilocaine—Pain—Glipizide—type 2 diabetes mellitus	0.0016	0.00234	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NEUROD1—type 2 diabetes mellitus	0.0016	0.00511	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ANK1—type 2 diabetes mellitus	0.0016	0.0051	CbGpPWpGaD
Prilocaine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00159	0.00232	CcSEcCtD
Prilocaine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00158	0.00231	CcSEcCtD
Prilocaine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00157	0.00229	CcSEcCtD
Prilocaine—Tension—Gliclazide—type 2 diabetes mellitus	0.00156	0.00228	CcSEcCtD
Prilocaine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00156	0.00227	CcSEcCtD
Prilocaine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00156	0.00227	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—LAMA1—type 2 diabetes mellitus	0.00155	0.00496	CbGpPWpGaD
Prilocaine—Bradycardia—Metformin—type 2 diabetes mellitus	0.00155	0.00227	CcSEcCtD
Prilocaine—Shock—Bromocriptine—type 2 diabetes mellitus	0.00155	0.00227	CcSEcCtD
Prilocaine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00155	0.00226	CcSEcCtD
Prilocaine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00155	0.00226	CcSEcCtD
Prilocaine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00155	0.00226	CcSEcCtD
Prilocaine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00154	0.00225	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SCN1B—type 2 diabetes mellitus	0.00154	0.00492	CbGpPWpGaD
Prilocaine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00154	0.00224	CcSEcCtD
Prilocaine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.00152	0.00222	CcSEcCtD
Prilocaine—Pain—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00218	CcSEcCtD
Prilocaine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00149	0.00218	CcSEcCtD
Prilocaine—Tremor—Gliclazide—type 2 diabetes mellitus	0.00149	0.00217	CcSEcCtD
Prilocaine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00148	0.00216	CcSEcCtD
Prilocaine—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.00148	0.00216	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SCN1B—type 2 diabetes mellitus	0.00148	0.00472	CbGpPWpGaD
Prilocaine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00215	CcSEcCtD
Prilocaine—Anaemia—Gliclazide—type 2 diabetes mellitus	0.00147	0.00214	CcSEcCtD
Prilocaine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00147	0.00214	CcSEcCtD
Prilocaine—Confusional state—Glyburide—type 2 diabetes mellitus	0.00146	0.00212	CcSEcCtD
Prilocaine—Sweating—Losartan—type 2 diabetes mellitus	0.00145	0.00211	CcSEcCtD
Prilocaine—Oedema—Glyburide—type 2 diabetes mellitus	0.00144	0.00211	CcSEcCtD
Prilocaine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00144	0.00211	CcSEcCtD
Prilocaine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00144	0.0021	CcSEcCtD
Prilocaine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00144	0.0021	CcSEcCtD
Prilocaine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.00143	0.00209	CcSEcCtD
Prilocaine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00143	0.00209	CcSEcCtD
Prilocaine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00143	0.00208	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SCN1B—type 2 diabetes mellitus	0.00143	0.00456	CbGpPWpGaD
Prilocaine—Shock—Glyburide—type 2 diabetes mellitus	0.00142	0.00207	CcSEcCtD
Prilocaine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00207	CcSEcCtD
Prilocaine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00142	0.00207	CcSEcCtD
Prilocaine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00142	0.00207	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—SCN1B—type 2 diabetes mellitus	0.00141	0.00449	CbGpPWpGaD
Prilocaine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.0014	0.00205	CcSEcCtD
Prilocaine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.0014	0.00204	CcSEcCtD
Prilocaine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.0014	0.00204	CcSEcCtD
Prilocaine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00139	0.00203	CcSEcCtD
Prilocaine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00202	CcSEcCtD
Prilocaine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00138	0.00202	CcSEcCtD
Prilocaine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00138	0.00201	CcSEcCtD
Prilocaine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00137	0.002	CcSEcCtD
Prilocaine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00136	0.00198	CcSEcCtD
Prilocaine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00135	0.00197	CcSEcCtD
Prilocaine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.00135	0.00197	CcSEcCtD
Prilocaine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00135	0.00197	CcSEcCtD
Prilocaine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00135	0.00197	CcSEcCtD
Prilocaine—Asthenia—Glipizide—type 2 diabetes mellitus	0.00135	0.00196	CcSEcCtD
Prilocaine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.00134	0.00196	CcSEcCtD
Prilocaine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00132	0.00193	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—MAFA—type 2 diabetes mellitus	0.00132	0.00423	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PAX4—type 2 diabetes mellitus	0.00131	0.00418	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TRPC1—type 2 diabetes mellitus	0.00131	0.00418	CbGpPWpGaD
Prilocaine—Syncope—Valsartan—type 2 diabetes mellitus	0.00131	0.00191	CcSEcCtD
Prilocaine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00131	0.00191	CcSEcCtD
Prilocaine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.0013	0.0019	CcSEcCtD
Prilocaine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.0013	0.00189	CcSEcCtD
Prilocaine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00129	0.00188	CcSEcCtD
Prilocaine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00129	0.00188	CcSEcCtD
Prilocaine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00129	0.00188	CcSEcCtD
Prilocaine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00129	0.00188	CcSEcCtD
Prilocaine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00128	0.00187	CcSEcCtD
Prilocaine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00127	0.00186	CcSEcCtD
Prilocaine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00127	0.00186	CcSEcCtD
Prilocaine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00127	0.00185	CcSEcCtD
Prilocaine—Tinnitus—Losartan—type 2 diabetes mellitus	0.00126	0.00185	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PAX4—type 2 diabetes mellitus	0.00126	0.00402	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TRPC1—type 2 diabetes mellitus	0.00126	0.00402	CbGpPWpGaD
Prilocaine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00126	0.00183	CcSEcCtD
Prilocaine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00125	0.00183	CcSEcCtD
Prilocaine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00125	0.00183	CcSEcCtD
Prilocaine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00125	0.00183	CcSEcCtD
Prilocaine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00183	CcSEcCtD
Prilocaine—Tremor—Metformin—type 2 diabetes mellitus	0.00124	0.00182	CcSEcCtD
Prilocaine—Sweating—Ramipril—type 2 diabetes mellitus	0.00124	0.00181	CcSEcCtD
Prilocaine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00124	0.00181	CcSEcCtD
Prilocaine—Anxiety—Valsartan—type 2 diabetes mellitus	0.00124	0.00181	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—ANK1—type 2 diabetes mellitus	0.00123	0.00393	CbGpPWpGaD
Prilocaine—Tension—Irbesartan—type 2 diabetes mellitus	0.00123	0.0018	CcSEcCtD
Prilocaine—Anxiety—Orlistat—type 2 diabetes mellitus	0.00122	0.00179	CcSEcCtD
Prilocaine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00122	0.00178	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—TRPC1—type 2 diabetes mellitus	0.00121	0.00387	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PAX4—type 2 diabetes mellitus	0.00121	0.00387	CbGpPWpGaD
Prilocaine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00121	0.00177	CcSEcCtD
Prilocaine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00121	0.00177	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NKX6-1—type 2 diabetes mellitus	0.00121	0.00386	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—LAMA1—type 2 diabetes mellitus	0.0012	0.00382	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—TRPC1—type 2 diabetes mellitus	0.0012	0.00382	CbGpPWpGaD
Prilocaine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00119	0.00174	CcSEcCtD
Prilocaine—Syncope—Metformin—type 2 diabetes mellitus	0.00119	0.00174	CcSEcCtD
Prilocaine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00119	0.00174	CcSEcCtD
Prilocaine—Oedema—Valsartan—type 2 diabetes mellitus	0.00119	0.00174	CcSEcCtD
Prilocaine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00119	0.00174	CcSEcCtD
Prilocaine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00119	0.00173	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ANK1—type 2 diabetes mellitus	0.00118	0.00378	CbGpPWpGaD
Prilocaine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00118	0.00173	CcSEcCtD
Prilocaine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00118	0.00172	CcSEcCtD
Prilocaine—Oedema—Orlistat—type 2 diabetes mellitus	0.00118	0.00172	CcSEcCtD
Prilocaine—Tremor—Irbesartan—type 2 diabetes mellitus	0.00117	0.00172	CcSEcCtD
Prilocaine—Shock—Valsartan—type 2 diabetes mellitus	0.00117	0.00171	CcSEcCtD
Prilocaine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00117	0.00171	CcSEcCtD
Prilocaine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00117	0.0017	CcSEcCtD
Prilocaine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00116	0.0017	CcSEcCtD
Prilocaine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00116	0.00169	CcSEcCtD
Prilocaine—Tension—Losartan—type 2 diabetes mellitus	0.00116	0.00169	CcSEcCtD
Prilocaine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00116	0.00169	CcSEcCtD
Prilocaine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00115	0.00168	CcSEcCtD
Prilocaine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00115	0.00168	CcSEcCtD
Prilocaine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00115	0.00168	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—LAMA1—type 2 diabetes mellitus	0.00115	0.00367	CbGpPWpGaD
Prilocaine—Hypertension—Metformin—type 2 diabetes mellitus	0.00115	0.00167	CcSEcCtD
Prilocaine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00115	0.00167	CcSEcCtD
Prilocaine—Nervousness—Losartan—type 2 diabetes mellitus	0.00115	0.00167	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—ANK1—type 2 diabetes mellitus	0.00114	0.00364	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—INS—type 2 diabetes mellitus	0.00114	0.00363	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00114	0.00166	CcSEcCtD
Prilocaine—Tocainide—CYP1A2—type 2 diabetes mellitus	0.00114	0.634	CrCbGaD
Prilocaine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00165	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00113	0.0036	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NEUROD1—type 2 diabetes mellitus	0.00113	0.00359	CbGpPWpGaD
Prilocaine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00112	0.00164	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—ANK1—type 2 diabetes mellitus	0.00112	0.00359	CbGpPWpGaD
Prilocaine—Nausea—Glipizide—type 2 diabetes mellitus	0.00111	0.00163	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HNF1A—type 2 diabetes mellitus	0.00111	0.00355	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PDX1—type 2 diabetes mellitus	0.00111	0.00355	CbGpPWpGaD
Prilocaine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00111	0.00162	CcSEcCtD
Prilocaine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00111	0.00162	CcSEcCtD
Prilocaine—Vision blurred—Losartan—type 2 diabetes mellitus	0.00111	0.00162	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—LAMA1—type 2 diabetes mellitus	0.00111	0.00354	CbGpPWpGaD
Prilocaine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00111	0.00162	CcSEcCtD
Prilocaine—Pain—Gliclazide—type 2 diabetes mellitus	0.00111	0.00162	CcSEcCtD
Prilocaine—Tremor—Losartan—type 2 diabetes mellitus	0.00111	0.00161	CcSEcCtD
Prilocaine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.0011	0.00161	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—type 2 diabetes mellitus	0.0011	0.00351	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.0011	0.00351	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—LAMA1—type 2 diabetes mellitus	0.00109	0.00349	CbGpPWpGaD
Prilocaine—Anaemia—Losartan—type 2 diabetes mellitus	0.00109	0.00159	CcSEcCtD
Prilocaine—Oedema—Metformin—type 2 diabetes mellitus	0.00108	0.00158	CcSEcCtD
Prilocaine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00108	0.00158	CcSEcCtD
Prilocaine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00108	0.00158	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PDX1—type 2 diabetes mellitus	0.00107	0.00342	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HNF1A—type 2 diabetes mellitus	0.00107	0.00342	CbGpPWpGaD
Prilocaine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00107	0.00156	CcSEcCtD
Prilocaine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00107	0.00156	CcSEcCtD
Prilocaine—Shock—Metformin—type 2 diabetes mellitus	0.00107	0.00156	CcSEcCtD
Prilocaine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00106	0.00155	CcSEcCtD
Prilocaine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00106	0.00155	CcSEcCtD
Prilocaine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00106	0.00155	CcSEcCtD
Prilocaine—Somnolence—Valsartan—type 2 diabetes mellitus	0.00106	0.00155	CcSEcCtD
Prilocaine—Syncope—Losartan—type 2 diabetes mellitus	0.00106	0.00155	CcSEcCtD
Prilocaine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00106	0.00154	CcSEcCtD
Prilocaine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00105	0.00153	CcSEcCtD
Prilocaine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00152	CcSEcCtD
Prilocaine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00104	0.00152	CcSEcCtD
Prilocaine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00104	0.00152	CcSEcCtD
Prilocaine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00104	0.00151	CcSEcCtD
Prilocaine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00104	0.00151	CcSEcCtD
Prilocaine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00104	0.00151	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PDX1—type 2 diabetes mellitus	0.00103	0.00329	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HNF1A—type 2 diabetes mellitus	0.00103	0.00329	CbGpPWpGaD
Prilocaine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00103	0.0015	CcSEcCtD
Prilocaine—Oedema—Irbesartan—type 2 diabetes mellitus	0.00102	0.00149	CcSEcCtD
Prilocaine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00102	0.00149	CcSEcCtD
Prilocaine—Hypotension—Metformin—type 2 diabetes mellitus	0.00101	0.00148	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA6—type 2 diabetes mellitus	0.00101	0.00322	CbGpPWpGaD
Prilocaine—Shock—Irbesartan—type 2 diabetes mellitus	0.00101	0.00147	CcSEcCtD
Prilocaine—Pain—Orlistat—type 2 diabetes mellitus	0.00101	0.00147	CcSEcCtD
Prilocaine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.001	0.00147	CcSEcCtD
Prilocaine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.001	0.00147	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SCN1B—type 2 diabetes mellitus	0.001	0.0032	CbGpPWpGaD
Prilocaine—Anxiety—Losartan—type 2 diabetes mellitus	0.001	0.00146	CcSEcCtD
Prilocaine—Tension—Ramipril—type 2 diabetes mellitus	0.000993	0.00145	CcSEcCtD
Prilocaine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000989	0.00144	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000985	0.00314	CbGpPWpGaD
Prilocaine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000983	0.00143	CcSEcCtD
Prilocaine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000974	0.00142	CcSEcCtD
Prilocaine—Confusional state—Losartan—type 2 diabetes mellitus	0.000971	0.00142	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOA6—type 2 diabetes mellitus	0.00097	0.0031	CbGpPWpGaD
Prilocaine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00097	0.00142	CcSEcCtD
Prilocaine—Somnolence—Metformin—type 2 diabetes mellitus	0.000964	0.00141	CcSEcCtD
Prilocaine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000963	0.00141	CcSEcCtD
Prilocaine—Oedema—Losartan—type 2 diabetes mellitus	0.000963	0.00141	CcSEcCtD
Prilocaine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000956	0.0014	CcSEcCtD
Prilocaine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000955	0.00139	CcSEcCtD
Prilocaine—Tremor—Ramipril—type 2 diabetes mellitus	0.000948	0.00138	CcSEcCtD
Prilocaine—Shock—Losartan—type 2 diabetes mellitus	0.000948	0.00138	CcSEcCtD
Prilocaine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000946	0.00138	CcSEcCtD
Prilocaine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000945	0.00138	CcSEcCtD
Prilocaine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000938	0.00137	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA6—type 2 diabetes mellitus	0.000935	0.00299	CbGpPWpGaD
Prilocaine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000935	0.00136	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000933	0.00298	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000931	0.00136	CcSEcCtD
Prilocaine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00093	0.00136	CcSEcCtD
Prilocaine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000919	0.00134	CcSEcCtD
Prilocaine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000918	0.00134	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000912	0.00291	CbGpPWpGaD
Prilocaine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00091	0.00133	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000908	0.0029	CbGpPWpGaD
Prilocaine—Syncope—Ramipril—type 2 diabetes mellitus	0.000907	0.00132	CcSEcCtD
Prilocaine—Hypotension—Losartan—type 2 diabetes mellitus	0.0009	0.00131	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000896	0.00286	CbGpPWpGaD
Prilocaine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000894	0.0013	CcSEcCtD
Prilocaine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000889	0.0013	CcSEcCtD
Prilocaine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000877	0.00128	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000876	0.0028	CbGpPWpGaD
Prilocaine—Pain—Irbesartan—type 2 diabetes mellitus	0.000875	0.00128	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000872	0.00278	CbGpPWpGaD
Prilocaine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000867	0.00127	CcSEcCtD
Prilocaine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000865	0.00126	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000864	0.00276	CbGpPWpGaD
Prilocaine—Urticaria—Metformin—type 2 diabetes mellitus	0.000862	0.00126	CcSEcCtD
Prilocaine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000859	0.00125	CcSEcCtD
Prilocaine—Nausea—Glyburide—type 2 diabetes mellitus	0.000857	0.00125	CcSEcCtD
Prilocaine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000857	0.00125	CcSEcCtD
Prilocaine—Somnolence—Losartan—type 2 diabetes mellitus	0.000856	0.00125	CcSEcCtD
Prilocaine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000854	0.00125	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—TRPC1—type 2 diabetes mellitus	0.000853	0.00272	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PAX4—type 2 diabetes mellitus	0.000853	0.00272	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000844	0.0027	CbGpPWpGaD
Prilocaine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000844	0.00123	CcSEcCtD
Prilocaine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000843	0.00123	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000841	0.00268	CbGpPWpGaD
Prilocaine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000833	0.00122	CcSEcCtD
Prilocaine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000826	0.00121	CcSEcCtD
Prilocaine—Oedema—Ramipril—type 2 diabetes mellitus	0.000826	0.00121	CcSEcCtD
Prilocaine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000824	0.0012	CcSEcCtD
Prilocaine—Pain—Losartan—type 2 diabetes mellitus	0.000824	0.0012	CcSEcCtD
Prilocaine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000813	0.00119	CcSEcCtD
Prilocaine—Shock—Ramipril—type 2 diabetes mellitus	0.000813	0.00119	CcSEcCtD
Prilocaine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00081	0.00118	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—ANK1—type 2 diabetes mellitus	0.000802	0.00256	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000798	0.00117	CcSEcCtD
Prilocaine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000794	0.00116	CcSEcCtD
Prilocaine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000788	0.00115	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000787	0.00251	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000781	0.00249	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LAMA1—type 2 diabetes mellitus	0.00078	0.00249	CbGpPWpGaD
Prilocaine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000778	0.00114	CcSEcCtD
Prilocaine—Asthenia—Metformin—type 2 diabetes mellitus	0.000778	0.00114	CcSEcCtD
Prilocaine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000772	0.00113	CcSEcCtD
Prilocaine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00077	0.00112	CcSEcCtD
Prilocaine—Urticaria—Losartan—type 2 diabetes mellitus	0.000765	0.00112	CcSEcCtD
Prilocaine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000757	0.00111	CcSEcCtD
Prilocaine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000754	0.0011	CcSEcCtD
Prilocaine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000748	0.00109	CcSEcCtD
Prilocaine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000742	0.00108	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000736	0.00235	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000736	0.00235	CbGpPWpGaD
Prilocaine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000734	0.00107	CcSEcCtD
Prilocaine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000734	0.00107	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000726	0.00232	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PDX1—type 2 diabetes mellitus	0.000725	0.00232	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HNF1A—type 2 diabetes mellitus	0.000725	0.00232	CbGpPWpGaD
Prilocaine—Dizziness—Metformin—type 2 diabetes mellitus	0.000717	0.00105	CcSEcCtD
Prilocaine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00071	0.00104	CcSEcCtD
Prilocaine—Nausea—Valsartan—type 2 diabetes mellitus	0.000707	0.00103	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000705	0.00225	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000702	0.00224	CbGpPWpGaD
Prilocaine—Nausea—Orlistat—type 2 diabetes mellitus	0.000699	0.00102	CcSEcCtD
Prilocaine—Asthenia—Losartan—type 2 diabetes mellitus	0.000691	0.00101	CcSEcCtD
Prilocaine—Vomiting—Metformin—type 2 diabetes mellitus	0.00069	0.00101	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000688	0.0022	CbGpPWpGaD
Prilocaine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000681	0.000994	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000677	0.00216	CbGpPWpGaD
Prilocaine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000677	0.000988	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000675	0.00215	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—GCK—type 2 diabetes mellitus	0.00067	0.00214	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000666	0.00213	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000661	0.00211	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—type 2 diabetes mellitus	0.00066	0.00211	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA6—type 2 diabetes mellitus	0.000657	0.0021	CbGpPWpGaD
Prilocaine—Tocainide—ALB—type 2 diabetes mellitus	0.000656	0.366	CrCbGaD
Prilocaine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000656	0.000958	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000653	0.00208	CbGpPWpGaD
Prilocaine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000651	0.00095	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.00065	0.00208	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.00065	0.00208	CbGpPWpGaD
Prilocaine—Nausea—Metformin—type 2 diabetes mellitus	0.000644	0.00094	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000644	0.00206	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.00064	0.00204	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000637	0.00203	CbGpPWpGaD
Prilocaine—Dizziness—Losartan—type 2 diabetes mellitus	0.000637	0.00093	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000632	0.00202	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000625	0.002	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000623	0.00199	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000621	0.00198	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000618	0.00197	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000617	0.00197	CbGpPWpGaD
Prilocaine—Vomiting—Losartan—type 2 diabetes mellitus	0.000612	0.000894	CcSEcCtD
Prilocaine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000608	0.000888	CcSEcCtD
Prilocaine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000608	0.000887	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000608	0.00194	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000603	0.00192	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000601	0.00192	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000598	0.00191	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000594	0.0019	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000593	0.00189	CbGpPWpGaD
Prilocaine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000593	0.000865	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000591	0.00189	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000578	0.00184	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000577	0.00184	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000575	0.00184	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000572	0.00183	CbGpPWpGaD
Prilocaine—Nausea—Losartan—type 2 diabetes mellitus	0.000572	0.000835	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000557	0.00178	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000552	0.00176	CbGpPWpGaD
Prilocaine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000546	0.000797	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.00053	0.00169	CbGpPWpGaD
Prilocaine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000525	0.000767	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000521	0.00166	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000511	0.00163	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000501	0.0016	CbGpPWpGaD
Prilocaine—Nausea—Ramipril—type 2 diabetes mellitus	0.000491	0.000716	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000483	0.00154	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000459	0.00147	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000457	0.00146	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000449	0.00143	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000448	0.00143	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000437	0.00139	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000434	0.00139	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000432	0.00138	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000424	0.00135	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000416	0.00133	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000409	0.00131	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000405	0.00129	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000402	0.00128	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000393	0.00125	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000392	0.00125	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000389	0.00124	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000379	0.00121	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000373	0.00119	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000361	0.00115	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CD36—type 2 diabetes mellitus	0.00036	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.00036	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000357	0.00114	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000347	0.00111	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000343	0.00109	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.00034	0.00108	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000335	0.00107	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000334	0.00107	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000329	0.00105	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000318	0.00101	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000303	0.000968	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000299	0.000954	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—INS—type 2 diabetes mellitus	0.000293	0.000935	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000293	0.000934	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000289	0.000922	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000287	0.000916	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000283	0.000904	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—INS—type 2 diabetes mellitus	0.000281	0.000899	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000277	0.000886	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000277	0.000883	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000272	0.000868	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—INS—type 2 diabetes mellitus	0.000271	0.000866	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000268	0.000854	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000266	0.000851	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SRC—type 2 diabetes mellitus	0.000266	0.00085	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000262	0.000837	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.00026	0.000829	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000259	0.000828	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SRC—type 2 diabetes mellitus	0.000256	0.000817	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000253	0.000808	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000249	0.000796	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SRC—type 2 diabetes mellitus	0.000247	0.000788	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000242	0.000772	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.00024	0.000767	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000235	0.000751	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000233	0.000745	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000232	0.000742	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000224	0.000716	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000224	0.000715	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000223	0.000713	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000216	0.00069	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.00021	0.000669	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000206	0.000658	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000204	0.000651	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000198	0.000632	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000196	0.000625	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000195	0.000621	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000191	0.00061	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—INS—type 2 diabetes mellitus	0.000191	0.000609	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—type 2 diabetes mellitus	0.00019	0.000607	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000189	0.000603	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000188	0.000601	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000185	0.000591	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000184	0.000589	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000183	0.000583	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—type 2 diabetes mellitus	0.000179	0.000573	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000178	0.000568	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000176	0.000562	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—type 2 diabetes mellitus	0.000173	0.000554	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—type 2 diabetes mellitus	0.000172	0.00055	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000171	0.000547	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.00017	0.000542	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000169	0.000539	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000167	0.000532	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—type 2 diabetes mellitus	0.000166	0.000531	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000163	0.000521	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.00016	0.000511	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000159	0.000506	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000157	0.000503	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000157	0.000502	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000154	0.000493	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000152	0.000487	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000152	0.000485	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000147	0.000469	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000134	0.000429	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000133	0.000424	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—type 2 diabetes mellitus	0.000128	0.000409	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000124	0.000395	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—type 2 diabetes mellitus	0.000123	0.000393	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000121	0.000385	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—type 2 diabetes mellitus	0.000119	0.000379	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—type 2 diabetes mellitus	0.000118	0.000377	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	0.000117	0.000373	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—type 2 diabetes mellitus	0.000113	0.000362	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000111	0.000353	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	0.000109	0.000349	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000108	0.000346	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000103	0.00033	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	8.34e-05	0.000266	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	7.69e-05	0.000246	CbGpPWpGaD
